Skip to main content
. 2022 Aug 17;7(8):190. doi: 10.3390/tropicalmed7080190

Table A3.

Disease progression rate: θ.

Parameters Description Value: Years Source
1/θ1I course of wild strain carriers in stage 1 4 [14]
1/θ2I course of wild strain carriers in stage 2 6 [14]
1/θ3I course of wild strain carriers in stage 3 2 [14]
1/θ1R course of drug-resistant carriers in stage 1 4 [14,39,40]
1/θ2R course of drug-resistant carriers in stage 2 6 [14,39,40]
1/θ3R course of drug-resistant carriers in stage 3 2 [14,39,40]